Results
|
|
1.
|
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2022
Citation: - Cardiovascular Diabetology. 21(1):167, 2022 Aug 30.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Meta-Analysis
All authors: - Fretts AM, Hoofnagle AN, Howard BV, Jensen PN, King IB, Lemaitre RN, McKnight B, Siscovick DS, Sitlani CM, Sotoodehnia N, Umans JG
|
|
|
2.
|
|
|
|
3.
|
Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study. MedStar authors:
Year: 2017
Citation: - Cardiovascular Diabetology. 16(1):64, 2017 05 12
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Best LG, de Simone G, Devereux RB, Howard BV, Izzo R, Lee ET, Mancusi C, Roman MJ, Wang W, Yeh F
|
|
|
4.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
